17 interviews and contributions
Interviews and media contributions.
These articles and interviews cover GLP-1 access, affordability and what patients actually go through. Some include my perspective as a patient or an advocate. For others I helped a journalist reach patients who wanted to tell their own story. Each entry says which it was.
2026
6 featuresFeb 5, 2026
KXCR Community Radio (Oregon) ↗
Oregon lags behind most states in GLP-1 use
Interviewed on air
Feb 23, 2026
The New York Times ↗
Exercise and weight-loss drugs
Helped connect patients with the reporter
Apr 2, 2026
Business Insider ↗
She lost 100 pounds on Zepbound. Then her insurance cut her off
Background interview on GLP-1 insurance coverage, and connected patients for interviews
Apr 2026
WLRN (South Florida Public Media)
GLP-1 access in Florida
Interviewed
Jul 6, 2026
NBC News ↗
Whether GLP-1s are worth the cost
Background interview by phone, and connected a patient for the story
Aug 24, 2026
Marketplace Morning Report (APM) ↗
Fewer employers are covering GLP-1 drugs for weight loss. Should they?
Interviewed on the cost of staying on GLP-1s and safer ways to access them
2025
7 featuresMar 2, 2025
USA Today ↗
FDA decisions on compounded GLP-1 medications
Quoted as a patient source on compounded medications
Mar 5, 2025
Childhood Obesity News ↗
FDA ends compounding for popular GLP-1 drugs
Advocacy work cited in the article
Mar 12, 2025
Fast Company ↗
Compounded Wegovy and Zepbound may disappear under new FDA rules
Quoted as a patient source on regulatory changes
Apr 1, 2025
KRLD NewsRadio 1080 (Audacy) ↗
FDA bans compounded weight-loss drugs
Interviewed on air about the compounding decision
May 14, 2025
Wired ↗
GLP-1 copycats and the compounded medication landscape
Quoted as a patient source on compounded medications
May 23, 2025
Reuters ↗
Amid compounding crackdown, US patients struggle as weight-loss drug discounts fall
Interviewed as a patient about access to compounded medications
Oct 20, 2025
Danish Broadcasting Corporation (DR) ↗
On Novo Nordisk litigation and patient advocacy concerns
Interviewed as a patient advocate on Novo Nordisk litigation
2024
4 featuresNov 26, 2024
Politico Prescription Pulse ↗
On GLP-1 patient petitions to the FDA
Quoted as a patient source on the national access petition
Dec 1, 2024
USA Today ↗
High prices push consumers to seek weight-loss drug alternatives
Quoted as a patient source on medication affordability
Dec 19, 2024
ABC Local 5 News (Iowa) ↗
Urging FDA to support GLP-1 compounding alternatives
Interviewed as a patient advocate on the petition
Dec 24, 2024
CNBC ↗
FDA Zepbound shortage impact and patient alternatives
Quoted as a patient source on access